Amyl Therapeutics Email Formats
Biotechnology Research • 
Ans, Walloon Region, Belgium • 11-20 Employees
Amyl Therapeutics Email Formats
Amyl Therapeutics uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@amyltx.com), used 76.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@amyltx.com | 84.6% |
{first initial}.{last name} | j.doe@amyltx.com | 15.4% |
Key Contacts at Amyl Therapeutics
Pierre Vandepapeliè
Chief Executive Officer
Julie Goemaere
R&D Director
Luis Fdo Villalobos
Director General
Company overview
| Headquarters | Boulevard Patience et Beaujonc, 3/12, Liège, Walloon Region 4000, BE |
| Website | |
| NAICS | 541714 |
| Keywords | Alzheimer, Parkinson, Biopharmaceutical Research, Amyloidosis |
| Founded | 2020 |
| Employees | 11-20 |
| Socials |
About Amyl Therapeutics
Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating severe peripheral amyloid protein misfolding diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we aim to make a transformative impact on the lives of patients affected by neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, or by systemic amyloidosis. Our approach is shaped by an experienced team with deep drug development experience, and productive collaborations with world-class advisors and partners.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Amyl Therapeutics has 11 employees across 6 departments.
Departments
Number of employees
Amyl Therapeutics Tech Stack
Discover the technologies and tools that power Amyl Therapeutics's digital infrastructure, from frameworks to analytics platforms.
CDN
CDN
JavaScript libraries
Miscellaneous
Security
Miscellaneous
Hosting
JavaScript libraries
Page builders
Miscellaneous
Mobile frameworks
CDN
United States
Singapore
Frequently asked questions
4.8
40,000 users
